Non ‑covalent proteasome inhibitor PI‑1840 induces apoptosis and autophagy in osteosarcoma cells.
In conclusion, the present study revealed PI‑1840 to be a promising drug for the treatment of OS.
PMID: 30864717 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
More News: Adenoviruses | Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Chemistry | Chemotherapy | Children | Osteosarcoma | Study